Cyclosporin treatment of glomerular diseases

Expert Opinion on Investigational Drugs

Volumn 9, Issue 5, 2000, Pages 1053-1063

  Halevy, D ^a   Radhakrishnan, J ^a  

^a PH4124 ^*  (United States)

Author keywords

Cyclosporin; Glomerular disease; Nephrotic syndrome; Toxicity; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

CLINICAL TRIAL; DRUG MECHANISM; GINGIVA HYPERPLASIA; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GOUT; HIRSUTISM; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPERURICEMIA; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTOXICITY; NEUROTOXICITY; REVIEW;

EID: 0034094042     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.5.1053     Document Type: Review

References (73)